Health Care: Drugs

Anika Therapeutics Inc (ANIK: NASDAQ)

$49.2 0.22 | 0.45%
02/21/17 - 04:00 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 103.38M 93.00M 105.59M 75.08M
Cost of Sales 24.03M 17.28M 16.22M 17.99M
Gross Operating Profit 79.35M 75.72M 89.37M 57.09M
Selling, General, and Administrative Expenses 18.01M 14.82M 15.07M 12.94M
Research & Development 10.73M 8.99M 8.14M 7.06M
Operating Income before D & A (EBITDA) 50.61M 51.91M 66.15M 37.09M
Depreciation & Amortization n.a. 3.77M 4.71M 4.77M
Interest Income 263.00K 120.00K 58.00K 0.00
Other Income - Net 0.00 0.00 0.00 0.00
Special Income / Charges n.a. 0.00 0.00 287.00K
Total Income Before Interest Expenses (EBIT) 50.87M 48.25M 61.51M 32.61M
Interest Expense 0.00 0.00 0.00 127.00K
Pre-Tax Income 50.87M 48.25M 61.51M 32.48M
Income Taxes 18.32M 17.50M 23.19M 11.90M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 32.55M 30.76M 38.32M 20.57M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 32.55M 30.76M 38.32M 20.57M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 32.55M 30.76M 38.32M 20.57M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
n.a. 30.76M 38.32M 20.29M
Preferred Dividends
Net Income Available To Common 0.00 30.76M 38.32M 20.57M
Basic EPS from Continuing Ops. 2.22 2.06 2.61 1.46
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 2.22 2.06 2.61 1.46
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 2.22 2.06 2.61 1.46
Basic Normalized Net Income/Share n.a. 2.06 2.61 1.44
EPS fr Continuing Ops. 2.15 2.01 2.51 1.39
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 2.15 2.01 2.51 1.39
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 2.15 2.01 2.51 1.39
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
n.a. 2.01 2.51 1.37
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ANIK

Latest ANIK Headlines from TheStreet

More Financial News for ANIK

Press Releases for ANIK

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter